Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Annovis Bio Inc
(NY:
ANVS
)
6.850
+0.920 (+15.51%)
Official Closing Price
Updated: 7:00 PM EDT, May 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Annovis Bio Inc
< Previous
1
2
3
4
5
Next >
28 Stocks Moving in Thursday's Pre-Market Session
July 29, 2021
Gainers LendingClub Corporation (NYSE: LC) shares rose 44.6% to $23.49 in pre-market trading after the company reported better-than-expected Q2 results and raised guidance. Acer...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch
July 23, 2021
Annovis bucked the trend depressing Alzheimer's stocks on Friday as ANVS stock touched a record high while SAVA stock and INMB stock fell.
Via
Investor's Business Daily
Annovis Bio's Alzheimer's Candidate To Proceed Into Final Cohort Of Mid-Stage Study, Data Expected In 2022
July 20, 2021
Data Safety Monitoring Board (DSMB) has reviewed safety and tolerability data for Cohort 2 of Annovis Bio Inc's (NYSE: ANVS) Phase 2 Alzheimer's disease trial...
Via
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Got $2,500? Check Out These 3 Alzheimer's Therapy Stocks
July 17, 2021
Treating Alzheimer's is extremely difficult, but these innovative companies are taking a stab at it.
Via
The Motley Fool
Here's Why The Biotech Stocks You Bought Keep Going Down
July 17, 2021
Good news! There's a way to avoid this portfolio pain -- and it doesn't involve avoiding the whole sector.
Via
The Motley Fool
Better Biotech Stock: Biogen vs. Annovis Bio
July 16, 2021
Both are making Alzheimer's drugs, but only one can claim success as of today.
Via
The Motley Fool
58 Biggest Movers From Yesterday
July 13, 2021
Gainers MediaCo Holding Inc. (NASDAQ: MDIA) shares jumped 311.6% to close at $17.00 on Monday after jumping 20% on Friday. State Auto Financial Corporation (NASDAQ: STFC) shares...
Via
Benzinga
38 Stocks Moving In Monday's Mid-Day Session
July 12, 2021
Gainers State Auto Financial Corporation (NASDAQ: STFC) shares jumped 189.5% to $49.96 after the company agreed to be acquired by Liberty Mutual Insurance for $52 per share in...
Via
Benzinga
Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021
July 04, 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
July 04, 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date ...
Via
Benzinga
44 Biggest Movers From Yesterday
June 23, 2021
Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its...
Via
Benzinga
These 2 Biotech Stocks Are Up 1,000% This Year
June 16, 2021
New approaches to treating Alzheimer's could mean even bigger gains in the future.
Via
The Motley Fool
Biotechs Ready To Roar
June 13, 2021
The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...
Via
Talk Markets
Exposures
Product Safety
Stocks That Hit 52-Week Highs On Thursday
June 17, 2021
This morning 94 companies set new 52-week highs. Things to Consider: NVIDIA (NASDAQ:NVDA) was the largest firm by market cap to set a new 52-week high. Deswell Industries...
Via
Benzinga
64 Biggest Movers From Friday
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
46 Stocks Moving In Friday's Mid-Day Session
June 11, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Ignore Biogen: 3 Reasons These Stocks Will Be Better Alzheimer's Investments
June 11, 2021
Data doesn't lie. These companies have the potential to quickly steal the spotlight.
Via
The Motley Fool
Exposures
Product Safety
This Biotech Stock Is Up 884% In 2021, But It Could Go Even Higher
June 10, 2021
With updates from clinical trials expected as soon as this month, anything is possible.
Via
The Motley Fool
Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use?
June 08, 2021
Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure.
Via
Investor's Business Daily
Annovis' Alzheimer's/Parkinson's Candidate Protects Nerve Cells Against Ill Effects of Higher Neurotoxic Proteins
June 08, 2021
Annovis Bio Inc (NYSE: ANVS) has announced preliminary data demonstrating that ANVS401 protects certain nerve cells from dying after being infected by gingipains, which...
Via
Benzinga
Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You Rich
June 07, 2021
There are better options for investors looking to profit from potential Alzheimer's disease treatments.
Via
The Motley Fool
Exposures
Product Safety
Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab
June 07, 2021
The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.
Via
Investor's Business Daily
Exposures
Product Safety
68 Biggest Movers From Yesterday
June 02, 2021
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached...
Via
Benzinga
54 Biggest Movers From Yesterday
May 26, 2021
Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended...
Via
Benzinga
22 Stocks Moving in Monday's Pre-Market Session
May 24, 2021
Gainers Virgin Galactic Holdings, Inc. (NYSE: SPCE) rose 29.3% to $27.25 in pre-market trading. Virgin Galactic’s VSS Unity spacecraft completed its first spaceflight from...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises
May 24, 2021
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones surged over 100 points in the previous session. Investors are awaiting earnings...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
48 Biggest Movers From Friday
May 24, 2021
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug...
Via
Benzinga
5 Stocks To Watch For May 24, 2021
May 24, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Nordson Corporation (NASDAQ: NDSN) to report quarterly earnings at $1.64 per share on revenue of $...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.